Sudden Cardiac Death - a Predictable,Avoidable and Treatable Event? 1

Gilman JK Jalal S Naccarelli GV . Predicting and preventing sudden death from cardiac causes. Circulation 1994; 90:1083–92.

Cohn PF . Predictive value of measures of myocardial ischemia in patients who have had a myocardial infarction. Cardiac Electrophysiology Review 1997; 1/2:205–6.

Viskin S Barron HV . Prediction of sudden death after myocardial infarction: value of electrophysiologic parameters. Cardiac Electrophysiology Review 1997; 1/2:193–7.

Bigger JT . The predictive value of RR variability and baroreflex sensitivity in coronary heart disease. Cardiac Electrophysiology Review 1997; 1/2:198–204.

Domanski MJ Zipes DP Schron E . Treatment of sudden cardiac death. Current understandings from randomized trials and future research directions. Circulation 1997; 95:2694–9.

The Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304:801–7.

β-blocker heart attack trial. A randomized trial of propranolol in patients with acute myocardial infarction. I Mortality results. JAMA 1982; 247:1707–14.

The Cardiac Arrhythmia Suppression Trial (CAST) investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406–12.

The Cardiac Arrhythmia Suppression Trial II investigators. Effect of the anti-arrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327:227–33.

Cairns JA Connolly SJ Roberts R Gent M . Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997; 349:675–82.

Teo KK Yusuf S Furberg CD . Effects of prophylactic anti-arrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993; 270:1589–95.

Bigger JT . Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 1997; 337:1569–75.

Siebels J Kuck K-H . Implantable cardioverter defibrillator compared with anti-arrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 1994; 127:1139–44.

The ESVEM Investigators. Determinants of predicted efficacy of antiarrhythmic drugs in the electrophysiologic study versus electrocardiographic monitoring trial. Circulation 1993; 87:323–9.

The CASCADE Investigators. Randomized anti-arrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol 1993; 72:280–7.

The anti-arrhythmics versus implantable defibrillators (AVID) investigators. A comparison of anti arrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576–83.

McKenna WJ, Sharma S. Arrhythmias and sudden death in hypertrophic cardiomyopathy. Epidemiology, pathophysiology, primary prevention, immediate evaluation and management, long-term management, experimental and theoretical developments. Cardiac Electrophysiology Review 1997; 1/2:229–32.

Vincent GM Timothy K Zhang L . Congenital long QT syndrome. Cardiac Electrophysiology Review 1997; 1/2:258–61.

Maron BJ . The young competitive athlete: causes of sudden death, detection, preparticipation screening, and standards for disqualification with cardiovascular abnormalities. Cardiac Electrophysiology Review 1997; 1/2:274–7.

Adgey AAJ Johnston PW McMechan S . Sudden cardiac death and substance abuse. Resuscitation 1995; 29:219–21.

Boon NA . Solvent abuse and the heart. BMJ 1987; 294:722.